Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GeneCapture
AddedFeb 15, 2024
UpdatedJun 18, 2026
GeneCapture

GeneCapture

Seed

GeneCapture: Pioneering RNA-based diagnostics and manufacturing medical instruments since 2010.

HQ
Huntsville, AL, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Founded in 2010, GeneCapture is an RNA-based diagnostic company focused on developing portable solutions for rapid pathogen identification and antibiotic susceptibility testing. With a core mission to revolutionize point-of-care diagnostics, GeneCapture manufactures medical, surgical, ophthalmic, and veterinary instruments. The company aims to provide healthcare professionals with quick and accurate diagnostic tools to improve patient outcomes and combat antibiotic resistance.

Notable affiliated people include a team of dedicated scientists who drive innovation in the field of RNA diagnostics. GeneCapture has garnered attention from key investors in the medical technology sector. Among its significant achievements is the development of a portable diagnostic device capable of detecting pathogens and determining their antibiotic susceptibility in real-time. This breakthrough has the potential to significantly impact global healthcare by enabling timely and precise treatment decisions.

GeneCapture - Similar Companies

PathoGene logo

PathoGene

Specific Diagnostics logo

Specific Diagnostics

Guanine logo

Guanine

guanineinc.com

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

ID Genomics logo

ID Genomics

idgenomics.com

Genendeavor logo

Genendeavor

genendeavor.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Molecular Detection logo

Molecular Detection

DxNA logo

DxNA

OmniVis logo

OmniVis

IncellDx logo

IncellDx

healthbioai.com

SenGenix logo

SenGenix

sengenix.com

First Light Diagnostics logo

First Light Diagnostics

firstlightbio.com

Attogene logo

Attogene

attogene.com

Torus Biosystems logo

Torus Biosystems

GeneCapture - Quick Facts

Who are GeneCapture's competitors?

Companies similar to GeneCapture include PathoGene, Specific Diagnostics, Guanine and BioAmp diagnostics.

When was GeneCapture founded?

GeneCapture was founded in 2009.

Where is GeneCapture's headquarters located?

GeneCapture's headquarters is located in Huntsville, AL, US.

How much has GeneCapture raised to-date?

As of Mar 23, 2023, GeneCapture has raised a total of $1.9M (USD).

How many employees does GeneCapture have?

GeneCapture has 44 employees as of Feb 5, 2024.

GeneCapture - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostics
  • Medical Devices
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified